Most Read Articles
Rachel Soon, 16 Aug 2019

On 8 August, the first town hall held by the Ministry of Health (MOH) with members of the pharmacy profession took place in Putrajaya. Over 500 pharmacists from across the country and from different areas of practice—community and hospital, public and private, academy and industry—converged to fill the auditorium for the chance to engage in direct dialogue with MOH.

3 days ago
Cardiac biomarkers are useful for identifying community-acquired pneumonia (CAP) patients with an elevated risk of early and long-term cardiovascular (CV) events, according to a study.
23 hours ago
Tofogliflozin is safe and effective for elderly patients with type 2 diabetes mellitus (T2DM), regardless of insulin and oral antidiabetic drugs, reports a new Japan study.
5 days ago
Pulmonary function has potential predictive value for future increases in arterial stiffness and its progression, as reported in a recent study.

Remote CBT works better than treatment as usual in refractory IBS

11 Jul 2019

Cognitive behavioural therapy (CBT), delivered over the web or phone, yields superior improvements in irritable bowel syndrome (IBS) symptoms and more favourable effects on life and mood in comparison with treatment as usual (TAU), according to data from the ACTIB* trial.

Researchers conducted a three-arm randomized controlled trial, including 558 IBS patients (mean age, 43.1 years; 75.8 percent female) who were assigned to receive telephone-delivered CBT (TCBT; n=186), web-based CBT (WCBT) with minimal therapist support (n=185) or TAU (n=187). All patients had refractory IBS (clinically significant symptoms for ≥12 months despite first-line therapies).

Of the patients, 70.1 percent completed 12 months of follow-up. The primary outcomes of interest were IBS Symptom Severity Score (IBS-SSS) and Work and Social Adjustment Scale (WSAS) at 12 months.

Compared with TAU, both TCBT and WCBT significantly reduced IBS-SSS (mean differences, 61.6 and 35.2 points; p<0.001 and p=0.002, respectively). More patients in both CBT arms achieved a clinically significant change in IBS-SSS (50 points) from baseline to 12 months (72.8 percent in TCBT; 66.1 percent in WCBT; 44.3 percent in TAU).

Similar results were observed with respect to the effect of IBS symptoms on the ability to work and manage at home, participate in social and private leisure activities, and maintain relationships. Specifically, WSAS score was lower by 3.5 points (p<0.001) in the TCBT arm and by 3.0 points in the WCBT arm than in the TAU arm at 12 months (p<0.001 and p=0.001, respectively).

Furthermore, both CBT interventions produced significantly greater improvements on all secondary outcomes (IBS-SSS and WSAS at 3 and 6 months after randomization; mood, symptom relief and ability to cope with symptoms at 3, 6 and 12 months) compared with TAU.

No serious adverse reactions to treatment were seen.

The findings of the current trial reinforce NICE guidance, which currently relies on a limited evidence base of mostly face-to-face CBT, the researchers pointed out. Patients with refractory IBS can benefit from CBT for IBS and that telephone-delivered or web-delivered CBT can provide sustained improvements.

*Assessing Cognitive–behavioural Therapy in Irritable Bowel syndrome

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Rachel Soon, 16 Aug 2019

On 8 August, the first town hall held by the Ministry of Health (MOH) with members of the pharmacy profession took place in Putrajaya. Over 500 pharmacists from across the country and from different areas of practice—community and hospital, public and private, academy and industry—converged to fill the auditorium for the chance to engage in direct dialogue with MOH.

3 days ago
Cardiac biomarkers are useful for identifying community-acquired pneumonia (CAP) patients with an elevated risk of early and long-term cardiovascular (CV) events, according to a study.
23 hours ago
Tofogliflozin is safe and effective for elderly patients with type 2 diabetes mellitus (T2DM), regardless of insulin and oral antidiabetic drugs, reports a new Japan study.
5 days ago
Pulmonary function has potential predictive value for future increases in arterial stiffness and its progression, as reported in a recent study.